GABA Agonists Inhibit the Vasopressin-Dependent Pressor Effects of Central Angiotensin II
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 39 (5) , 429-436
- https://doi.org/10.1159/000124016
Abstract
Previous studies have demonstrated that intraventricular (IVT) administration of low doses of gamma-amino-butyric acid (GABA) agonists reduced the pressor effects of centrally injected angiotensin II (AII). The following studies were designed to determine if GABA agonists acted to inhibit the pressor response of AII through blockade of the vasopressin-dependent pressor component. Following pretreatment with a vascular vasopressin antagonist, the pressor response of IVT administered AII was reduced approximately 50%. Hypophysectomy produced a similar reduction in this pressor response. These results suggested that vasopressin contributed to one-half of the pressor response of AIL In order to generate a vasopressin-dependent response, the sympathetic nervous system was eliminated with ganglionic blockade by chlorisondamine. The increase in arterial pressure produced by IVT injected AII after ganglionic blockade was augmented compared to untreated rats. This potentiated pressor effect of IVT administered AII after chlorisondamine treatment was markedly reduced by a vascular vasopressin antagonist or by hypophysectomy. Therefore, the pressor effect of AII after ganglionic blockade was caused principally by the pressor actions of arginine-vasopressin (AVP). This AVP-dependent pressor effect of IVT injected AII was reduced by pretreatment with 100 µg of GABA or 50 ng of the GABA agonist muscimol. These doses of GABA and muscimol have previously been shown to reduce the pressor response of IVT administered AII by approximately 60% in untreated rats. Thus, pretreatment with low doses of GABA agonists reduced the pressor effect of IVT injected AII in part by inhibiting the vasopressin component of this response. The inhibitory effect of GABA on vasopressin secretion was confirmed by the observation that GABA pretreatment also blocked the increase in plasma AVP levels produced by IVT administered AIIKeywords
This publication has 14 references indexed in Scilit:
- Central blood pressure effects of substance P and angiotensin II: Role of the sympathetic nervous system and vasopressinEuropean Journal of Pharmacology, 1981
- Satiety and inhibition of vasopressin secretion after drinking in dehydrated dogsAmerican Journal of Physiology-Endocrinology and Metabolism, 1981
- Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin releasePflügers Archiv - European Journal of Physiology, 1980
- Central nervous system mechanisms involving GABA influence arterial pressure and heart rate in the cat.Circulation Research, 1980
- [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1980
- Cardiovascular effects elicited from the ventral surface of medulla oblongata in the catPflügers Archiv - European Journal of Physiology, 1980
- Central antihypertensive properties of muscimol and related γ-aminobutyric acid agonists and the interaction of muscimol with baroreceptor reflexesCanadian Journal of Physiology and Pharmacology, 1979
- Vasopressin-mediated blood pressure response to intraventricular injection of angiotensin II in the ratPflügers Archiv - European Journal of Physiology, 1978
- Stimulation of food intake by muscimol and beta endorphinNeuropharmacology, 1977
- Hypophysectomy and a replacement therapy in the ratJournal of Anatomy, 1930